Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 82.48% is in line with its 5-year average of 77.26%, near the high end of its 5-year range (61.49%–83.51%).
As of the fiscal period ended Tuesday, March 31, 2026. 0.95% above its 12-month average of 81.71%.
Reported quarterly gross margin; no daily interpolation.
GROSS MARGIN
82.48%
GROSS MARGIN AVG TTM
81.71%
GROSS MARGIN AVG 3Y
82.13%
GROSS MARGIN AVG 5Y
77.26%
GROSS MARGIN AVG 10Y
79.81%
GROSS MARGIN AVG 15Y
80.37%
GROSS MARGIN AVG 20Y
80.68%
CURRENT VS TTM AVG
+0.95%
CURRENT VS 3Y AVG
+0.43%
CURRENT VS 5Y AVG
+6.76%
CURRENT VS 10Y AVG
+3.35%
CURRENT VS 15Y AVG
+2.63%
CURRENT VS 20Y AVG
+2.23%
SECTOR MEDIAN · HEALTHCARE
58.51%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
+40.97%
vs the sector median at left
Market Cap
$129.13B
Gross Margin
63.67%
TTM Avg
62.91%
3Y Avg
61.66%
5Y Avg
61.70%
Market Cap
$127.75B
Gross Margin
68.75%
TTM Avg
62.23%
3Y Avg
59.55%
5Y Avg
57.82%
Market Cap
$126.06B
Gross Margin
66.68%
TTM Avg
66.73%
3Y Avg
66.82%
5Y Avg
67.04%
Market Cap
$138.14B
Gross Margin
58.51%
TTM Avg
60.22%
3Y Avg
59.98%
5Y Avg
59.48%
Market Cap
$121.57B
Gross Margin
86.28%
TTM Avg
85.57%
3Y Avg
86.56%
5Y Avg
87.08%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| AstraZeneca PLC (AZN) | $131.45B | 82.48% | 81.71% | 82.13% | 77.26% |
| Stryker Corporation (SYK)vs › | $129.13B | 63.67% | 62.91% | 61.66% | 61.70% |
| Bristol-Myers Squibb Company (BMY)vs › | $127.75B | 68.75% | 62.23% | 59.55% | 57.82% |
| CVS Health Corp. (CVS)vs › | $136.61B | 13.87% | 13.78% | 14.92% | 15.96% |
| Intuitive Surgical, Inc. (ISRG)vs › | $126.06B | 66.68% | 66.73% | 66.82% | 67.04% |
| Danaher Corporation (DHR)vs › | $138.14B | 58.51% | 60.22% | 59.98% | 59.48% |
| Pfizer Inc. (PFE)vs › | $140.61B | 69.35% | 68.05% | 62.23% | 63.06% |
| Vertex Pharmaceuticals Incorporated (VRTX)vs › | $121.57B | 86.28% | 85.57% | 86.56% | 87.08% |
| Medtronic plc (MDT)vs › | $107.81B | 65.02% | 65.17% | 65.34% | 65.75% |
| GSK plc (GSK)vs › | $104.87B | 72.67% | 71.78% | 70.69% | 69.52% |
Gross Margin
82.5%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-03-31 | 82.48% |
| 2025-12-31 | 79.89% |
| 2025-09-30 | 81.56% |
| 2025-06-30 | 82.89% |
| 2025-03-30 | 83.51% |
| 2024-12-31 | 81.70% |
| 2024-09-30 | 77.29% |
| 2024-06-30 | 83.13% |
| 2024-03-31 | 82.51% |
| 2023-12-31 | 80.81% |
| 2023-09-30 | 81.77% |
| 2023-06-30 | 82.83% |
| 2023-03-31 | 82.49% |
| 2022-12-31 | 74.12% |
| 2022-09-30 | 72.85% |
| 2022-06-30 | 72.17% |
| 2022-03-31 | 69.17% |
| 2021-12-31 | 61.49% |
| 2021-09-30 | 61.92% |
| 2021-06-30 | 73.35% |
| 2021-03-31 | 74.54% |
| 2020-12-31 | 79.42% |
| 2020-09-30 | 79.17% |
| 2020-06-30 | 84.32% |
| 2020-03-31 | 77.65% |
| 2019-12-31 | 79.32% |
| 2019-09-30 | 78.91% |
| 2019-06-30 | 81.74% |
| 2019-03-31 | 79.44% |
| 2018-12-31 | 74.49% |
| 2018-09-30 | 78.41% |
| 2018-06-30 | 80.37% |
| 2018-03-31 | 78.10% |
| 2017-12-31 | 78.80% |
| 2017-09-30 | 79.96% |
| 2017-06-30 | 81.19% |
| 2017-03-31 | 83.46% |
| 2016-12-31 | 79.23% |
| 2016-09-30 | 84.21% |
| 2016-06-30 | 81.05% |
| 2016-03-31 | 83.58% |
| 2015-12-31 | 80.17% |
| 2015-09-30 | 82.49% |
| 2015-06-30 | 83.08% |
| 2015-03-31 | 79.05% |
| 2014-12-31 | 75.06% |
| 2014-09-30 | 78.59% |
| 2014-06-30 | 80.67% |
| 2014-03-31 | 77.51% |
| 2013-12-31 | 78.96% |
| 2013-09-30 | 80.19% |
| 2013-06-30 | 78.87% |
| 2013-03-31 | 80.17% |
| 2012-12-31 | 80.80% |
| 2012-09-30 | 80.93% |
| 2012-06-30 | 79.79% |
| 2012-03-31 | 81.29% |
| 2011-12-31 | 81.38% |
| 2011-09-30 | 80.60% |
| 2011-06-30 | 82.42% |
| 2011-03-31 | 83.85% |
| 2010-12-31 | 79.59% |
| 2010-09-30 | 80.70% |
| 2010-06-30 | 82.25% |
| 2010-03-31 | 80.71% |
| 2009-12-31 | 81.39% |
| 2009-09-30 | 84.60% |
| 2009-06-30 | 81.60% |
| 2009-03-31 | 82.04% |
| 2008-12-31 | 74.22% |
| 2008-09-30 | 79.61% |
| 2008-06-30 | 82.01% |
| 2008-03-31 | 80.85% |
| 2007-12-31 | 73.79% |
| 2007-09-30 | 80.35% |
| 2007-06-30 | 79.80% |
| 2007-03-31 | 79.84% |
| 2006-12-31 | 77.94% |
| 2006-09-30 | 79.45% |
| 2006-06-30 | 79.00% |
| 2006-03-31 | 78.88% |
| 2005-12-31 | 77.92% |
| 2005-09-30 | 78.49% |
| 2005-06-30 | 78.59% |
| 2005-03-31 | 75.45% |
| 2004-12-31 | 74.91% |
| 2004-09-30 | 75.57% |
| 2004-06-30 | 76.34% |
| 2004-03-31 | 77.18% |
| 2003-12-31 | 78.32% |
| 2003-09-30 | 75.54% |
| 2003-06-30 | 75.16% |
| 2003-03-31 | 76.03% |
| 2002-12-31 | 77.79% |
| 2002-09-30 | 72.83% |
| 2002-06-30 | 75.42% |
